Hem CME/CE Courses – Update

Hematology CME/CE Courses

myCME Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

The Role of Maintenance Therapy and the Patient Voice in AML Treatment: A Virtual Case Clinic

Maintenance Therapy and the Patient Voice in AML | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists, ANCC Contact Hour(s)

1.25 CME CE: Complex case-based scenarios managing patients with AML through induction, consolidation, transplant, and maintenance therapies. Exp 8/11/23

Advances in Beta Thalassemia: Reducing Transfusion Burden With Novel Molecular Therapies

Beta Thalassemia Advances : Reducing Transfusion Burden | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: This interactive e-journal article covers pathophysiology, diagnostic criteria, clinical trial data, and transition preparedness strategies. Exp 3/11/2023

Targeting Treatment: Selecting Optimal Therapy for Vulnerable Patients

Optimal Therapy for Vulnerable Follicular Lymphoma Patients | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), ABIM MOC Points, CE for Pharmacists, AAPA Category I CME Credit

0.50 CME CE: This final installment in a 3-part series assesses the needs of older patients with FL when creating treatment plans. Exp. 3/9/2023

Key Questions Answered in the Management of Follicular Lymphoma

Management of Follicular Lymphoma | myCME

ANCC Contact Hour(s)

1.50 CE: Focuses on oncology nurse role in FL and discusses advances treatment, including updates to guidelines and two novel agents. Exp 4/29/23

Higher-Risk MDS: Novel Targets for Risk-Adapted Therapy

Novel Targets for Higher-risk Myelodysplastic Syndromes | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: Examine clinical data supporting the importance of differential diagnosis, risk stratification, and emerging therapies. Exp 2/24/23

Improving Outcomes through Maintenance Therapy in AML: Incorporating the Patient Voice into Long-Term Management Strategies

Improving Long-Term Outcomes in AML: Maintenance Therapy | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists, ANCC Contact Hour(s)

1.00 CME CE: An interactive infographic activity on AML maintenance therapy. Exp 7/15/23

The Pathologist’s Perspective: The Importance of Ring Sideroblast Quantification and Evaluation in Myelodysplastic Syndromes

Ring Sideroblast Quantification in Myelodysplastic Syndromes | myCME

AMA PRA Category 1 Credit(s)^TM

1.50 CME: Symposium on pathology of MDS-RS includes a cross-disciplinary interview enhanced by infographics and pathologist pocket guide. Exp 4/28/2023

Breakthroughs in Paroxysmal Nocturnal Hemoglobinuria Treatment: Targeting Alternative Pathways of Complement Inhibition

Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

1.00 CME CE: A lively expert discussion and real-world clinical case on PNH. Exp 6/30/23

Patient Simulation: Addressing Immune-Related Adverse Events in Patients Receiving Checkpoint Inhibitor Treatment

Immune Related Adverse Events in Checkpoint Inhibitor Treatment | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), AAPA Category I CME Credit

1.00 CME CE: This module will immerse clinicians in how to safely practice applying new clinical concepts in managing imAEs in patients receiving ICI treatment. Exp. 4/19/23

Optimizing Outcomes in Low-Risk Myelodysplastic Syndromes

Optimizing Outcomes in Low-Risk MDS | myCME

ANCC Contact Hour(s), IPCE Credit(s)

1.00 CE: In-depth discussion for healthcare practitioners who manage patients with low-risk MDS so they can to better recognize the types of MDS. Exp 4/29/23

Targeted Therapy for NSCLC: New Frontiers | myCME